Primary and Secondary Prevention of Ischemic Stroke and Cerebral Hemorrhage: JACC Focus Seminar

HC Diener, GJ Hankey - Journal of the American College of Cardiology, 2020 - jacc.org
Stroke is a leading cause of permanent disability. Therefore, primary prevention of first
stroke and secondary prevention of recurrent stroke are a high priority. Primary prevention of …

Lessons from 20 years with COX‐2 inhibitors: Importance of dose–response considerations and fair play in comparative trials

CO Stiller, P Hjemdahl - Journal of Internal Medicine, 2022 - Wiley Online Library
Nonsteroidal anti‐inflammatory drugs (NSAIDs) inhibit the enzyme cyclooxygenase (COX),
which forms prostaglandins involved in pain and inflammation. COX inhibitors have …

[HTML][HTML] Antiplatelet therapy after percutaneous coronary intervention

DJ Angiolillo, M Galli, JP Collet, A Kastrati… - …, 2022 - ncbi.nlm.nih.gov
Antiplatelet therapy is key to reducing local thrombotic complications and systemic
ischaemic events among patients undergoing percutaneous coronary interventions (PCI) …

Is acetylsalicylic acid a safe and potentially useful choice for adult patients with COVID-19?

V Bianconi, F Violi, F Fallarino, P Pignatelli… - Drugs, 2020 - Springer
Abstract Severe Acute Respiratory Syndrome–Coronavirus-2 is responsible for the current
pandemic that has led to more than 10 million confirmed cases of Coronavirus Disease-19 …

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and …

Authors/Task Force Members, L Rydén… - European heart …, 2013 - academic.oup.com
ESC Guidelines 3039 administrative staff and by the referees and supervisory committees of
the two organizations. It is our hope that this huge effort has generated guidelines that will …

[PDF][PDF] 2014 ESC/EACTS Guidelines on myocardial revascularization

S Windecker, P Kolh, F Alfonso… - Kardiologia Polska …, 2014 - journals.viamedica.pl
Zachęca się pracowników opieki zdrowotnej, aby w pełni uwzględniali te wytyczne
ESC/EACTS, gdy dokonują oceny klinicznej, a także kiedy określają i realizują medyczne …

Drug repurposing in cancer

L Sleire, HE Førde, IA Netland, L Leiss, BS Skeie… - Pharmacological …, 2017 - Elsevier
Cancer is a major health issue worldwide, and the global burden of cancer is expected to
increase in the coming years. Whereas the limited success with current therapies has driven …

Mechanisms, consequences, and prevention of coronary graft failure

M Gaudino, C Antoniades, U Benedetto, S Deb… - Circulation, 2017 - Am Heart Assoc
Graft failure occurs in a sizeable proportion of coronary artery bypass conduits. We herein
review relevant current evidence to give an overview of the incidence, pathophysiology, and …

Oral anticoagulant therapy: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines

W Ageno, AS Gallus, A Wittkowsky, M Crowther… - Chest, 2012 - Elsevier
Background The objective of this article is to summarize the published literature concerning
the pharmacokinetics and pharmacodynamics of oral anticoagulant drugs that are currently …

Inflammation and its resolution as determinants of acute coronary syndromes

P Libby, I Tabas, G Fredman, EA Fisher - Circulation research, 2014 - Am Heart Assoc
Inflammation contributes to many of the characteristics of plaques implicated in the
pathogenesis of acute coronary syndromes. Moreover, inflammatory pathways not only …